SYMPOSIA
SYMPOSIA
SYMPOSIA
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
[KL-04]<br />
Transcultural psychiatry: Practice and sample cases in USA and status in Turkiye<br />
Alican Dalkilic<br />
Virginia Commonwealth University, Richmond, VA & SEH, Washington, DC, USA<br />
E-mail: E-mail: drdalkilic@gmail.com<br />
Bulletin of Clinical Psychopharmacology, Vol: 21, Supplement: 2, 2011 - www.psikofarmakoloji.org<br />
Abstracts of the Invited Speakers<br />
Culture refers to unique behavior patterns and lifestyle shared by a group of people that distinguish it from other groups. The views, beliefs, values, and<br />
attitudes of a group characterize their culture. Culture and people influence and interact with each other reciprocally (1). In clinical practice patient’s<br />
culture, physician’s culture, and medical culture play a significant role. Adequate and appropriate understanding of cultural dimensions is essential for<br />
culturally competent practice (1). Also the impact of culture in evaluation and treatment of children and adolescents is significant in psychiatric patients (2).<br />
Cultural competency is a requirement for medical licensure in most states the US. To prove clinical competency clinicians are required<br />
demonstrate cultural competency. Clinicians typically work in multicultural and multiethnic societies (1). Ongoing globalization and<br />
interconnection of economies and rapidly spreading new social media platforms will increase diversity in all communities, but especially<br />
in developing countries including Turkiye. Therefore cultural competency training should be incorporated into residency training and<br />
continuous medical education systems especially for mental health clinicians.<br />
Clinicians should be familiar with culturally relevant relations and interactions of their patients (1), in order to establish therapeutic alliance and<br />
provide competent care and therapy besides demonstrating cultural sensitivity, knowledge, and empathy. Also most psychotherapies are based<br />
on Euro-American values of individualistic and egocentric concept, which can be contrasted with more sociocentric, ecocentric, and cosmocentric<br />
views (3). This issue should be taken into consideration when treating patients from other cultures or subcultures in the US and Europe.<br />
In this presentation I will review transcultural psychiatry practice in the US, provide and discuss some cases and summarize the status in Turkiye.<br />
Key words: Transcultural psychiatry, Turkish American cases, transcultural psychiatry in USA<br />
References:<br />
1. Focus, winter 2006 Vol. IV. No. 1, 81-89. Introduction: Culture and Psychiatry. Tseng W-S, Streltzer J.<br />
2. Child Adolesc Psychiatr Clin N Am. 2010 Oct;19(4):661-80. Culture and development in children and youth. Pumariega AJ, Joshi SV.<br />
3. Transcult Psychiatry. 2007 Jun;44(2):232-57. Psychotherapy and the cultural concept of the person. Kirmayer LJ<br />
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S37<br />
[KL-05]<br />
Medical marijuana use in psychiatry<br />
Tahir Tellioglu<br />
Brown University, Rhode Island Hospital Dept Psychiatry, Providence USA<br />
E-mail: TTellioglu@Lifespan.org<br />
Medical marijuana refers to the use of parts of the cannabis plant or synthetic forms of specific cannabinoids as a physician-recommended<br />
form of medicine. The cannabis plant has been known to have medicinal use as an analgesic, appetite stimulant, antiemetic, muscle<br />
relaxant and anticonvulsant agent. A number of clinical studies, some disputed, claim that cannabinoids present an interesting<br />
therapeutic potential as antiemetics, appetite stimulants in debilitating diseases (cancer and AIDS) and analgesics, and in the treatment<br />
of multiple sclerosis, spinal cord injuries, Tourette’s syndrome, epilepsy and glaucoma.<br />
Despite its illegality, patients have continued to obtain cannabis on the black market for self-medication for its self reported anti-anxiety<br />
or antidepressant effects. A survey of 3,000 patients in California from 1993-2000 revealed about 27% of individuals used it primarily for<br />
psychiatric conditions such as as an antidepressant or anxiolytic.<br />
Understanding the mechanisms of action of cannabinoids has revived therapeutic interest in these substances. However, clinical studies<br />
about the use of cannabis for psychiatric conditions are very limited. Further clinical trials, well-designed, carefully executed, and powered<br />
for efficacy, are essential to clearly define the role of cannabinoids in the treatment of psychiatric conditions.<br />
Key words: Medical marijuana, cannabis, psychiatric disorders<br />
Bulletin of Clinical Psychopharmacology 2011;21(Suppl. 2):S37<br />
S37